[Congressional Record Volume 167, Number 145 (Tuesday, August 10, 2021)]
[Senate]
[Pages S6356-S6357]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 3426. Mr. MARSHALL submitted an amendment intended to be proposed 
by him to the concurrent resolution S. Con. Res. 14, setting forth the 
congressional budget for the United States Government for fiscal year 
2022 and setting forth the appropriate budgetary levels for fiscal 
years 2023 through 2031; which was ordered to lie on the table; as 
follows:

       At the end of title III, add the following:

     SEC. 3004. DEFICIT-NEUTRAL RESERVE FUND RELATING TO 
                   INSTRUCTING THE GOVERNMENT ACCOUNTABILITY 
                   AGENCY TO INVESTIGATE DUAL-USE TECHNOLOGY AND 
                   BIOLOGICAL WEAPONS RESEARCH CONDUCTED BETWEEN 
                   CHINA AND THE DEFENSE THREAT REDUCTION AGENCY.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution, 
     and make adjustments to the pay-as-you-go ledger, for one or 
     more bills, joint resolutions, amendments, amendments between 
     the Houses, motions, or conference reports relating to 
     instructing the Government Accountability Agency to 
     investigate dual-use technology and biological weapons 
     research conducted between China and the Defense Threat 
     Reduction Agency by the amounts provided in such legislation 
     for those purposes, provided that such legislation would not 
     increase the deficit over either the period of the total of 
     fiscal years

[[Page S6357]]

     2022 through 2026 or the period of the total of fiscal years 
     2022 through 2031.
                                 ______